Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing funding for stem cell research and cancer research is expected to drive market growth.
4.1.2. Restraints:
4.1.2.1. High costs are expected to hamper the market’s growth in the forecast period.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces
5.2. Unmet Needs
5.3. Supply Chain
5.4. Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Cancer Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
7.1.2. Market Attractiveness Index, By Cancer Type Segment
7.2. Blood Cancer*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Breast Cancer
7.4. Colorectal Cancer
7.5. Lung Cancer
7.6. Liver Cancer
7.7. Brain Cancer
7.8. Others
8. By Mode of Action
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Action
8.1.2. Market Attractiveness Index, By Mode of Action Segment
8.2. Stem Cell-based Cancer Therapy*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.2.3. Autologous Stem Cell Transplant
8.2.4. Allogeneic Stem Cell Transplant
8.3. Targeted Cancerous Stem Cells (CSCs)
8.3.1. By Anti-Cancer Stem Cell Therapeutics
8.3.1.1. Pathway Inhibitors
8.3.1.1.1. WNT Signaling Pathway
8.3.1.1.2. Hedgehog Signaling Pathway
8.3.1.1.3. Notch Signaling Pathway
8.3.1.1.4. Others
8.3.1.2. Surface Marker-based
8.3.1.3. Immuno-evasion & Targeting Tumor Microenvironment
8.3.1.4. Nanoparticle-based Therapies
8.3.1.5. Others
8.3.2. By Products
8.3.2.1. Cell Culturing
8.3.2.2. Cell Separation
8.3.2.3. Cell Analysis
8.3.2.4. Molecular Analysis
8.3.2.5. Others
9. By End user
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
9.1.2. Market Attractiveness Index, By End user Segment
9.2. Specialised Cancer Treatment Centers*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Hospitals
9.4. Research Institutes
9.5. Other
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Action
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Action
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Action
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Action
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cancer Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Action
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
12. Company Profiles
12.1. Merck KGaA*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Merck KGaA
12.3. Thermo Fisher Scientific, Inc.
12.4. Bionomics.
12.5. AbbVie, Inc.
12.6. Stemline Therapeutics, Inc
12.7. LONZA
12.8. PromoCell GmbH
12.9. Miltenyi Biotec
12.10. STEMCELL Technologies Inc
12.11. BIOTIME, Inc
LIST NOT EXHAUSTIVE
13. Global Cancer Stem Cells Market – DataM
13.1. Appendix
13.2. About Us and Applications
13.3. Contact Us